References

Hyperuricemia and its related diseases: mechanisms and advances in therapy

10.1038/s41392-024-01916-y · 2024 · External reference

Prevalence of gout and hyperuricemia in the US General Population The National Health and Nutrition Examination Survey 2007-2008

10.1136/bmj.j2376 · 2011 · External reference

Prevalence of hyperuricemia and its associated factors in the general Korean population: an analysis of a population-based nationally representative sample

10.1007/s10067-018-4130-2 · 2018 · External reference

Prevalence of hyperuricemia among Chinese adults: findings from two nationally representative cross-sectional surveys in 2015-16 and 2018-19

10.3389/fimmu.2021.791983 · 2022 · External reference

Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies

10.1136/bmj.j2376 · 2017 · External reference

Xanthine oxidoreductase: one enzyme for multiple physiological tasks

10.1016/j.redox.2021.101882 · 2021 · External reference

Hyperuricemia in acute gastroenteritis is caused by decreased urate excretion via ABCG2

10.1038/srep31003 · 2016 · External reference

Regulation of uric acid excretion by the kidney

10.1007/s11926-012-0240-z · 2012 · External reference

SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout

10.1038/ng.106 · 2008 · External reference

GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes

10.1136/annrheumdis-2016-209632 · 2017 · External reference

Gout: an old disease in new perspective - a review

10.1016/j.jare.2017.04.008 · 2017 · External reference

Investigational drugs for hyperuricemia, an update on recent developments

10.1080/13543784.2018.1471133 · 2018 · External reference

Vine tea (Ampelopsis grossedentata): a review of chemical composition, functional properties, and potential food applications

10.1016/j.jff.2021.104842 · 2021 · External reference

Study on effects of processing technology and storage on the composition of Ampelopsis grossedentata by untargeted metabolomics

10.1016/j.foodres.2022.111867 · 2022 · External reference

Interactions of dihydromyricetin, a flavonoid from vine tea (Ampelopsis grossedentata) with gut microbiota

10.1111/1750-3841.14128 · 2018 · External reference

Research on the efficacy of ganpu vine tea in inhibiting uric acid production

10.3390/metabo13060704 · 2023 · External reference

Amelioration effects of α-viniferin on hyperuricemia and hyperuricemia-induced kidney injury in mice

10.1016/j.phymed.2023.154868 · 2023 · External reference

Chemical constituents and α-glucosidase inhibitory, antioxidant and hepatoprotective activities of Ampelopsis grossedentata

10.3390/molecules28247956 · 2023 · External reference

Detection and quantification of flavoalkaloids in different tea cultivars and during tea processing using UPLC-TOF-MS/MS

10.1016/j.foodchem.2020.127864 · 2021 · External reference

Development of improved process with treatment of cellulase for isolation of ampelopsin from dried fruits of Ampelopsis grossedentata

10.15376/biores.11.1.2712-2722 · 2016 · External reference

Antibacterial activities and mechanisms of vine tea extract and 2R,3R-dihydromyricetin on Escherichia coli

10.1016/j.lwt.2021.111393 · 2021 · External reference

Evaluation of changes in chemical composition and antioxidant activities from vine tea at different harvest times based on LC-MS, GC-MS, and data fusion algorithms

10.1016/j.fochx.2025.102363 · 2025 · External reference

Optimized extraction and determination of dihydromyricetin content from local and introduced Ampelopsis grossedentata to Zhejiang Province

10.3969/j.issn.1001-3776.2023.01.004 · 2023 · External reference

Study on flavonoids from Ampelopsis grossedentata in Lichuan City

2020 · External reference

Optimization of ultrasonic-assisted two-aqueous extraction of flavonoids from Rosa roxburghii Tratt and its inhibitory effect on xanthine oxidase activity

10.13386/j.issn1002-0306.2022100316 · 2023 · External reference

Anti-hyperuricemic effects of extracts from Chaenomeles speciosa (Sweet) Nakai fruits on hyperuricemic rats

10.3390/metabo14020117 · 2024 · External reference

In vitro evaluation of antiproliferative, lipoxygenase and xanthine oxidase inhibitory activities of Artemisia nilagirica (CB Clarke) Pamp. leaf extracts

10.36468/pharmaceutical-sciences.522 · 2019 · External reference

Recent advances in bioactivity evaluation methods of uric acid-lowering compounds

10.11665/j.issn.1000-5048.2023080103 · 2024 · External reference

Punicalagin attenuates hyperuricemia via restoring hyperuricemia-induced renal and intestinal dysfunctions

10.1016/j.jare.2024.03.029 · 2025 · External reference

Hyperuricemia research progress in model construction and traditional Chinese medicine interventions

10.3389/fphar.2024.1294755 · 2024 · External reference

The time-feature of uric acid excretion in hyperuricemia mice induced by potassium oxonate and adenine

10.3390/ijms21155178 · 2020 · External reference

Sanghuangporus vaninii ethanol extract alleviates hyperuricemic renal injury by regulating the uric acid transporters and inhibiting HK-2 apoptosis

10.1016/j.biopha.2023.114970 · 2023 · External reference

Recent update on the pharmacological effects and mechanisms of dihydromyricetin

10.3389/fphar.2018.01204 · 2018 · External reference

S. Li. Protective effect and mechanism of total flavonoids from Ampelopsis grossedentata on renal function injury of hyperuricemia based on molecular docking technology

10.7501/j.issn.0253-2670.2021.03.015 · 2021 · External reference

Metabolomics approach, in vitro and in vivo antioxidant activity assay provide insights into impact of multiple variations on the vine tea

10.1016/j.lwt.2023.114578 · 2023 · External reference

Exploring the therapeutic potential of Ampelopsis grossedentata leaf extract as an anti-inflammatory and antioxidant agent in human

10.3390/ijms25010416 · 2024 · External reference

Dietary dihydromyricetin supplementation enhances antioxidant capacity and improves lipid metabolism in finishing pigs

10.1039/d0fo03094e · 2021 · External reference

Dihydromyricetin enhances intestinal antioxidant capacity of growing-finishing pigs by activating ERK/Nrf2/HO-1 signaling pathway

10.3390/antiox11040704 · 2022 · External reference

Xanthine oxidoreductase regulates macrophage IL1β secretion upon NLRP3 inflammasome activation

10.1038/ncomms7555 · 2015 · External reference

Xanthine oxidase-derived reactive oxygen species activate nuclear factor kappa B during hepatic ischemia in rats

10.1254/jjp.84.363 · 2000 · External reference

Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease

10.1016/j.biopha.2021.111927 · 2021 · External reference

Dihydromyricetin attenuates cisplatin-induced acute kidney injury by reducing oxidative stress, inflammation and ferroptosis

10.1016/j.taap.2023.116595 · 2023 · External reference